By: David Miller, BSc, N.D., NHP Scientific Regulatory Associate February 21, 2011 The recent revisions to the status of Levocarnitine in the Canadian regulatory environment (http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/html/sor-dors275-eng.html) have Read More >>